Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
/ Aug 01, 2023
Panel Discussion on Sustainability: Green chemistry - driving the change for the greater good!
Read more
Scientific Article
/ Sep 18, 2023
Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics
Read more
Scientific Article
Scientific Article